Canada: Drug Advertising In The Context Of Social Media

Last Updated: January 25 2016
Article by Anushua Nag and André Rivest

Most Read Contributor in Canada, October 2018

Both in the U.S. and in Canada, advertising of prescription pharmaceutical products is highly regulated and can raise various challenges, which are heightened in the context of social media. The reason prescription pharmaceutical product ads are so widely found on American television is simple: the Unites States, along with New Zealand, are the only two countries to allow direct broadcasting of such advertisements to the general public (Direct-to-consumer/DTC advertising).  On the other end of the spectrum, Canadian law prohibits all direct-to-consumer ads for narcotics or controlled drugs.  As for prescription drug advertisements, they are limited to displaying only certain statutorily prescribed information.  However, since these regulations were developed in the context of traditional media, applying them is proving more complicated in the era of social networks, whether in Canada or in the U.S.  Restrictions on the number of characters, for example, can be quite mind-boggling when attempting to present all of the potential side effects associated with a drug!1

In Canada, pharmaceutical product advertisement is mainly regulated by the Food and Drugs Act (the "Canadian Act").  The basic rule of the Canadian Act states that no person shall advertise any drug in a manner that is false, misleading or deceptive, or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety.  Although direct-to-consumer advertising of prescription drugs is allowed, the Canadian Act prohibits anyone from presenting such drugs to the general public as being a treatment, preventative or cure for any of the diseases, disorders or abnormal physical states referred to in Schedule A.  Schedule A lists a wide range of medical conditions, from chronic anxiety to congestive heart failure.  Further, a prescription drug advertisement must limit itself to presenting information that is statutorily prescribed, such as the brand name, common name, true name, price and quantity of the drug.  These rules are less stringent in certain regards, particularly with respect to biologic drugs and over-the-counter drugs, but that is largely beyond the scope of this article. Also of note, the Canadian Act does not prohibit the broadcast of informational messages pertaining to a particular drug when such messages do not set out the product benefits or use.  In fact, insofar as they are not associated with a medical condition referred to in Schedule A, such messages (or help-seeking advertisements) are theoretically allowed.

Although it is clear that the above regulations apply to all forms of advertisement, no matter the broadcasting medium used, applying these rules to new media platforms is causing some confusion.  In the recent years, Advertising Standards Canada (ASC), the national not-for-profit advertising self-regulatory body, released a short checklist on the advertising of drugs directly to the general public in which it simply reminded companies that all advertisements, even when broadcasted on social networks, must include the information required under the Canadian Act.

In the U.S., pharmaceutical product advertisement is mainly regulated by the Food and Drug Administration (FDA) under the Food, Drug and Cosmetic Act (the "US Act").  The great importance attached to the constitutional protection of freedom of expression is one of the main reasons direct-to-consumer advertising of pharmaceutical products is authorized, but advertising agencies are not granted blanket authority with this regard.  Print ads, in addition to being truthful and non-misleading, must mandatorily contain certain information, including: i) the established name and commercial name of the drug; ii) their ingredients and quantities; and iii) a brief description of the side effects, contraindications and effectiveness associated with using the drug. There must also be a proper balance in the way the side effects, contraindications and effectiveness are presented. As for television and radio ads, the US Act provides that they may include only a brief disclosure of the main risks associated with the drug, as long as such ads provide a toll-free number that consumers may call to get full disclosure of this information.

In respect of social media, in its guidelines issued in June of 2014, the FDA advised that a company deciding to present the benefits of a certain drug must also make sure to set out the risks associated with that drug, no matter what limitations may be imposed by a social media platform with regards to the number of characters.  The FDA also urged companies to provide consumers access to more detailed information about the risks associated with using the product (by providing a link to a more detailed website, for example).  

As shown above, the rules related to the advertising of pharmaceutical products in Canada vary considerably from the rules applicable in the U.S. However, considering the free flow of information on social networks and the speed at which it travels on these platforms, messages originating in the U.S. will inevitably end up on Canadian consumers' home pages. Although this spillover may be concerning, considering the more permissive nature of the U.S. rules, it is currently not monitored. Health Canada has stated that it has no jurisdiction over messages originating from the U.S., whether these messages are transmitted via traditional or new media.

In the absence of any specific rules applicable to drug advertising in the context of social media, pharmaceutical companies wishing to advertising their products on the various new platforms must rely on general advertising rules and make sure to apply them integrally. A good practice would be to closely monitor any further guidance on this topic provided by Health Canada and the FDA. We will keep you updated on future developments.


1 Let us first note that this article focuses on product claim ads (as opposed to reminder ads, for example, which make no reference to a drug's effectiveness).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions